Search research articles
Contact Us
Filters
Showing results (51-60 of 122) with videos related to
Page
of 13
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
December 31, 2014
Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10
Darja Gramec Skledar, Johanna Troberg, Jason Lavdas, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 5, 2012
Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10
Barbara Fedejko-Kap, Stacie M Bratton, Moshe Finel, et al.
The FEBS Journal
|
February 1, 2007
Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33
Lydia Barre, Sylvie Fournel-Gigleux, Moshe Finel, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 19, 2009
Synthesis, structure characterization, and enzyme screening of clenbuterol glucuronides
Anna Alonen, Minna Gartman, Olli Aitio, et al.
International Journal of Pharmaceutics
|
September 8, 2009
Caco-2 cell monolayers as a tool to study simultaneous phase II metabolism and metabolite efflux of indomethacin, paracetamol and 1-naphthol
Sanna Siissalo, Laura Laine, Ari Tolonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 22, 2008
UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly
Taina Sten, Ingo Bichlmaier, Tiia Kuuranne, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 23, 2008
The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases
Katriina Itäaho, Peter I Mackenzie, Shin-ichi Ikushiro, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 13, 2008
The expression of most UDP-glucuronosyltransferases (UGTs) is increased significantly during Caco-2 cell differentiation, whereas UGT1A6 is highly expressed also in undifferentiated cells
Sanna Siissalo, Hongbo Zhang, Eric Stilgenbauer, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
August 28, 2010
Glucuronidation of racemic O-desmethyltramadol, the active metabolite of tramadol
Päivi Lehtonen, Taina Sten, Olli Aitio, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 25, 2013
Human UDP-glucuronosyltransferase (UGT) 2B10 in drug N-glucuronidation: substrate screening and comparison with UGT1A3 and UGT1A4
Yukiko Kato, Takeshi Izukawa, Shingo Oda, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 122) with videos related to
Sort By:
Page
of 13
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
December 31, 2014
Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10
Darja Gramec Skledar, Johanna Troberg, Jason Lavdas, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 5, 2012
Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10
Barbara Fedejko-Kap, Stacie M Bratton, Moshe Finel, et al.
The FEBS Journal
|
February 1, 2007
Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33
Lydia Barre, Sylvie Fournel-Gigleux, Moshe Finel, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 19, 2009
Synthesis, structure characterization, and enzyme screening of clenbuterol glucuronides
Anna Alonen, Minna Gartman, Olli Aitio, et al.
International Journal of Pharmaceutics
|
September 8, 2009
Caco-2 cell monolayers as a tool to study simultaneous phase II metabolism and metabolite efflux of indomethacin, paracetamol and 1-naphthol
Sanna Siissalo, Laura Laine, Ari Tolonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 22, 2008
UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly
Taina Sten, Ingo Bichlmaier, Tiia Kuuranne, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 23, 2008
The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases
Katriina Itäaho, Peter I Mackenzie, Shin-ichi Ikushiro, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 13, 2008
The expression of most UDP-glucuronosyltransferases (UGTs) is increased significantly during Caco-2 cell differentiation, whereas UGT1A6 is highly expressed also in undifferentiated cells
Sanna Siissalo, Hongbo Zhang, Eric Stilgenbauer, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
August 28, 2010
Glucuronidation of racemic O-desmethyltramadol, the active metabolite of tramadol
Päivi Lehtonen, Taina Sten, Olli Aitio, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 25, 2013
Human UDP-glucuronosyltransferase (UGT) 2B10 in drug N-glucuronidation: substrate screening and comparison with UGT1A3 and UGT1A4
Yukiko Kato, Takeshi Izukawa, Shingo Oda, et al.
Page
of 13